49 PEGINTRON MAINTENANCE THERAPY IN CIRRHOTIC (METAVIR F4) HCV PATIENTS, WHO FAILED TO RESPOND TO INTERFERON/RIBAVIRN (IR) THERAPY: FINAL RESULTS OF THE EPIC3 CIRRHOSIS MAINTENANCE TRIAL
Jordi BruixDept. of Hepatology and Gastroenterology,Thierry PoynardPitié-Salpêtrière HospitalMassimo ColomboInstitute of Nuclear Medicine,E. SchiffDept. of Visceral-and Transplantation Surgery, Essen University Hosptial, Essen, GermanyJürg ReichenUniversitaet Bern, Bern, Switzerland;Kelly W. BurakHeritage Medical Research Clinic -University of Calgary, Calgary, Alberta,E. Jenny HeathcoteUniversity Health Network -Toronto Western Hospital, Toronto, Ontario, Canada;Thomas BergCharit -Campus Virchow Klinikum, Berlin, Germany;J.L. Poo-RamírezCIF BIOTEC/Hospital Medica Sur, Mexico City, Mexico;Caique MelloHospital Universitario Gaffree & Guinle, Rio de Janeiro, Brazil;R. Kim GuentherUniversitaetsklinikum Schleswig-Holstein, Kiel, 12 St. Josef-Hospital Oberhausen, Oberhausen, Germany;C. NiederauRubén TergN. BopariJoann HarveyLouis GriffelMargaret BurroughsClifford A. BrassJ.K. Albrecht
ABI
Аннотация
Аннотация мавжуд эмас.
Мавзулар
Идентификаторлар
Иқтибослар ва манбалар
0 та иқтибос0 та фойдаланилган манба